SAN FRANCISCO–(BUSINESS WIRE)–Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the launch of the first non-absorbable, uni-directional barbed suture, part of its family of V-Loc™ wound closure devices.
Read more…
You may never have heard of this nutrient, but studies at the leading nutritional research laboratories point to the vitamin-like substance coenzyme Q10 (or CoQ10) as key to a fertility diet.
Read more…
The phase II, placebo-controlled trial, conducted in Ukraine by internationally recognized experts in the field of TB immunotherapy, was aimed to identify the efficacy of tableted, heat-killed Mycobacterium vaccae in TB patients, including re-treated TB, multi-drug resistant (MDR-TB) and TB with HIV co-infection. The preliminary results of the study support findings from a trial published last year in Immunotherapy journal by a clinical team lead by Professor John Stanford and his colleagues in Argentina.
Read more…
The U.S. Food and Drug Administration recently approved Byetta, a Type 2 diabetes medication created by Amylin Pharmaceuticals, Inc., for use in concert with insulin glargine—the most popular type of insulin, used around the world by diabetics.
Read more…
Adistem Ltd began a clinical trial at the end of 2009 into the safety/efficacy of delivering autologous adipose-derived stem cells into the fibrotic lungs of ill patients, can now report very promising results.
Read more…
